AstraZeneca cuts costs and doubles down on cancer drugs AstraZeneca is to cut costs by $1 billion and increase its focus on cancer treatments after underlying earnings, hit by drug patent expiries, fell 12 percent in the first quarter, broadly in line with analyst expectations.
Combination drug therapies for cancer show promise at higher potential cost CHICAGO—Cancer researchers see promise in giving patients combinations of multiple drugs that are proving more effective than one or two.
Cancer treatment untested in many patients with immune problems The safety and effectiveness of a new cancer treatment known as immunotherapy is largely unknown in patients with autoimmune diseases, researchers say - and that might account for up to a quarter of individuals with lung cancer.
Cancer cell therapies could be approved next year: Juno, Kite Pharma A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells could begin reaching patients next year, according to companies presenting new data at the annual meeting of the American Society of Clinical Oncology.
Roche therapy helps 24 percent of untreated bladder cancer patients: study A newly approved immunotherapy from Roche Holding proved effective as an initial treatment for some patients with advanced bladder cancer, according to data presented on Sunday.
Mindfulness program may reduce fear, fatigue for cancer survivors A tailored six-week mindfulness program may lead to small improvements in some physical and psychological symptoms that breast cancer survivors often experience, according to a new study.
Talc linked to ovarian cancer risk in African-American women African-American women who reported regular use of body powder were at greater risk for ovarian cancer compared to their peers who didn't use talc, a new study shows.
Promising drugs stoke talk of eventual cancer 'cure' Robert Waag is alive and apparently cancer free more than two years after advanced melanoma reached his lungs, hips and other parts of his body - a feat only recently considered unthinkable for such patients.
Risks of X-rays for cancer diagnosis may be a mystery to most patients Most patients lack basic knowledge about the risks of radiation exposure from X-rays and other diagnostic imaging tests used to detect cancer, a recent study suggests.
Diem Brown's legacy helps New York family battle brain cancer Diem Brown was an MTV reality star who competed in several fitness challenge shows while battling ovarian cancer.
